Jesus A. Gutierrez
Research Subjects
Jesus A. Gutierrez has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
John E. Hale
Hale Biochemical Consulting LLC, 97601, Klamath Falls, OR, USA
4 shared publications- Michael D. Knierman
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
4 shared publications Richard E. Higgs
Lilly Research Laboratories, Lilly Corporate Center, 46285, Indianapolis, IN, USA
3 shared publicationsJill A. Willency
2 shared publicationsPatricia J. Solenberg
2 shared publicationsValentina Gelfanova
Lilly Research Laboratories, Lilly Corporate Center, 46285, Indianapolis, IN, USA
2 shared publications
Latest Publications
- 21 May 2014
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 25 (7) , 1228-1236
A Quantitative Tool to Distinguish Isobaric Leucine and Isoleucine Residues for Mass Spectrometry-Based De Novo Monoclonal Antibody Sequencing
De novo sequencing by mass spectrometry (MS) allows for the determination of the complete amino acid (AA) sequence of a given protein based on the mass difference of detected ions from MS/MS fragmentation spectra. The technique relies on obtaining specific masses that can be attributed to characteristic theoretical masses of AAs. A major limitation of de novo sequencing by MS is the inability to distinguish between the isobaric residues leucine (Leu) and isoleucine (Ile). Incorrect identification of Ile as Leu or vice versa often results in loss of activity in recombinant antibodies. This functional ambiguity is commonly resolved with costly and time-consuming AA mutation and peptide sequencing experiments. Here, we describe a set of orthogonal biochemical protocols, which experimentally determine the identity of Ile or Leu residues in monoclonal antibodies (mAb) based on the selectivity that leucine aminopeptidase shows for n-terminal Leu residues and the cleavage preference for Leu by chymotrypsin. The resulting observations are combined with germline frequencies and incorporated into a logistic regression model, called Predictor for Xle Sites (PXleS) to provide a statistical likelihood for the identity of Leu at an ambiguous site. We demonstrate that PXleS can generate a probability for an Xle site in mAbs with 96% accuracy. The implementation of PXleS precludes the expression of several possible sequences and, therefore, reduces the overall time and resources required to go from spectra generation to a biologically active sequence for a mAb when an Ile or Leu residue is in question. Figure
- 21 May 2014
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 25 (7) , 1228-1236
A Quantitative Tool to Distinguish Isobaric Leucine and Isoleucine Residues for Mass Spectrometry-Based De Novo Monoclonal Antibody Sequencing
De novo sequencing by mass spectrometry (MS) allows for the determination of the complete amino acid (AA) sequence of a given protein based on the mass difference of detected ions from MS/MS fragmentation spectra. The technique relies on obtaining specific masses that can be attributed to characteristic theoretical masses of AAs. A major limitation of de novo sequencing by MS is the inability to distinguish between the isobaric residues leucine (Leu) and isoleucine (Ile). Incorrect identification of Ile as Leu or vice versa often results in loss of activity in recombinant antibodies. This functional ambiguity is commonly resolved with costly and time-consuming AA mutation and peptide sequencing experiments. Here, we describe a set of orthogonal biochemical protocols, which experimentally determine the identity of Ile or Leu residues in monoclonal antibodies (mAb) based on the selectivity that leucine aminopeptidase shows for n-terminal Leu residues and the cleavage preference for Leu by chymotrypsin. The resulting observations are combined with germline frequencies and incorporated into a logistic regression model, called Predictor for Xle Sites (PXleS) to provide a statistical likelihood for the identity of Leu at an ambiguous site. We demonstrate that PXleS can generate a probability for an Xle site in mAbs with 96% accuracy. The implementation of PXleS precludes the expression of several possible sequences and, therefore, reduces the overall time and resources required to go from spectra generation to a biologically active sequence for a mAb when an Ile or Leu residue is in question. Figure
- Top Cited Papers
- 29 April 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (17) , 6320-6325
Ghrelin octanoylation mediated by an orphan lipid transferase
The peptide hormone ghrelin is the only known protein modified with an O-linked octanoyl side group, which occurs on its third serine residue. This modification is crucial for ghrelin's physiological effects including regulation of feeding, adiposity, and insulin secretion. Despite the crucial role for octanoylation in the physiology of ghrelin, the lipid transferase that mediates this novel modification has remained unknown. Here we report the identification and characterization of human GOAT, the ghrelin O -acyl transferase. GOAT is a conserved orphan membrane-bound O -acyl transferase (MBOAT) that specifically octanoylates serine-3 of the ghrelin peptide. Transcripts for both GOAT and ghrelin occur predominantly in stomach and pancreas. GOAT is conserved across vertebrates, and genetic disruption of the GOAT gene in mice leads to complete absence of acylated ghrelin in circulation. The occurrence of ghrelin and GOAT in stomach and pancreas tissues demonstrates the relevance of GOAT in the acylation of ghrelin and further implicates acylated ghrelin in pancreatic function.
- 29 April 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (17) , 6320-6325
Top Cited PapersGhrelin octanoylation mediated by an orphan lipid transferase
The peptide hormone ghrelin is the only known protein modified with an O-linked octanoyl side group, which occurs on its third serine residue. This modification is crucial for ghrelin's physiological effects including regulation of feeding, adiposity, and insulin secretion. Despite the crucial role for octanoylation in the physiology of ghrelin, the lipid transferase that mediates this novel modification has remained unknown. Here we report the identification and characterization of human GOAT, the ghrelin O -acyl transferase. GOAT is a conserved orphan membrane-bound O -acyl transferase (MBOAT) that specifically octanoylates serine-3 of the ghrelin peptide. Transcripts for both GOAT and ghrelin occur predominantly in stomach and pancreas. GOAT is conserved across vertebrates, and genetic disruption of the GOAT gene in mice leads to complete absence of acylated ghrelin in circulation. The occurrence of ghrelin and GOAT in stomach and pancreas tissues demonstrates the relevance of GOAT in the acylation of ghrelin and further implicates acylated ghrelin in pancreatic function.
- Open Access
- 1 June 2005
- Published by Taylor & Francis in BioTechniques
- Vol. 38 (sup6) , 13-7
Quantitative Determination of Peptides Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
A method is described for the quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Known limitations imposed by crystal heterogeneity, peptide...
- 1 June 2005
- Published by Taylor & Francis in BioTechniques
- Vol. 38 (sup6) , 13-7
Open AccessQuantitative Determination of Peptides Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
A method is described for the quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Known limitations imposed by crystal heterogeneity, peptide...
- Open Access
- 1 July 2003
- Published by Wiley in Journal of Neurochemistry
- Vol. 86 (1) , 255-266
Characterization of a novel G‐protein coupled receptor from the parasitic nematode H. contortus with high affinity for serotonin
The neurotransmitter serotonin (5HT) has been shown to modulate mobility, feeding, egg‐laying, and defecation behaviors in the saprophytic nematode Caenorhabditis elegans. Although the effects of serotonin on these behaviors in parasitic nematodes is under study, little is known about the diversity, ontogeny, signaling, and pharmacology of serotonin receptors in these organisms. In an effort to increase our understanding of this system, we cloned and characterized a novel cDNA (5HT1Hc) from the parasitic nematode Haemonchus contortus that has high amino acid sequence homology with known G‐protein coupled 5HT1‐receptors from invertebrates and vertebrates. Transcript expression studies in four development stages (egg, L1/L2, L3, and adult) revealed the presence of the mRNA in the L1/L2, L3, and adult stages. Membranes from insect cells (Sf9) expressing the 5HT1Hc‐receptor cDNA displayed nanomolar binding affinity to serotonin and a unique pharmacological profile distinct from known invertebrate and mammalian 5HT‐receptors. Receptor signaling studies with mammalian AV12 cells expressing the 5HT1Hc‐receptor and the promiscuous G‐protein, Gα15, demonstrated dose‐dependent intracellular signals with serotonin acting as an agonist. Together, these studies describe a novel invertebrate 5HT‐receptor with high affinity for the indolealkylamine, serotonin, and pharmacological properties that do not conform to any known members of this superfamily of metabotropic receptors.
- 1 July 2003
- Published by Wiley in Journal of Neurochemistry
- Vol. 86 (1) , 255-266
Open AccessCharacterization of a novel G‐protein coupled receptor from the parasitic nematode H. contortus with high affinity for serotonin
The neurotransmitter serotonin (5HT) has been shown to modulate mobility, feeding, egg‐laying, and defecation behaviors in the saprophytic nematode Caenorhabditis elegans. Although the effects of serotonin on these behaviors in parasitic nematodes is under study, little is known about the diversity, ontogeny, signaling, and pharmacology of serotonin receptors in these organisms. In an effort to increase our understanding of this system, we cloned and characterized a novel cDNA (5HT1Hc) from the parasitic nematode Haemonchus contortus that has high amino acid sequence homology with known G‐protein coupled 5HT1‐receptors from invertebrates and vertebrates. Transcript expression studies in four development stages (egg, L1/L2, L3, and adult) revealed the presence of the mRNA in the L1/L2, L3, and adult stages. Membranes from insect cells (Sf9) expressing the 5HT1Hc‐receptor cDNA displayed nanomolar binding affinity to serotonin and a unique pharmacological profile distinct from known invertebrate and mammalian 5HT‐receptors. Receptor signaling studies with mammalian AV12 cells expressing the 5HT1Hc‐receptor and the promiscuous G‐protein, Gα15, demonstrated dose‐dependent intracellular signals with serotonin acting as an agonist. Together, these studies describe a novel invertebrate 5HT‐receptor with high affinity for the indolealkylamine, serotonin, and pharmacological properties that do not conform to any known members of this superfamily of metabotropic receptors.
- 13 March 2000
- Published by Elsevier in International Journal for Parasitology
- Vol. 30 (3) , 247-252
Genomics: from novel genes to new therapeutics in parasitology
- 13 March 2000
- Published by Elsevier in International Journal for Parasitology
- Vol. 30 (3) , 247-252
Genomics: from novel genes to new therapeutics in parasitology